Cite Filings / ALDX / 0000950170-25-104971

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Aldeyra Therapeutics, Inc. Filed 2025-08-07 Acc 0000950170-25-104971

Documents 1

10-Q Quarterly Report , aldx-20250630.htm

Around this filing

2025-11-05 10-Q Quarterly Report
2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-13 4 Chief Development Officer sold 22,073 shares at $5.15 ($113,713)
2025-08-12 144 Sale of Securities
2025-08-07 10-Q Quarterly Report
2025-05-14 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading aldx-20250630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…